Disha Mehta1, Daniela A Pimentel2, Maria-Zunilda Núñez3, Amir Abduljalil4, Vera Novak2. 1. Division of Gerontology, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, Palmer 117, Boston, MA 02215, USA. 2. Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, Palmer 127, Boston, MA 02215, USA. 3. Centro de Investigaciones Biomédicas y Clínicas (CINBIOCLI), Hospital José María Cabral y Báez, Av. 27 de Febrero, Santiago, Dominican Republic. 4. Department of Radiology, Ohio State University, 395W. 12th Avenue, Columbus, OH, USA.
Abstract
OBJECTIVE: Microalbuminuria (MA), a marker of renal microvascular disease, is associated with brain atrophy and neurovascular changes in older adults with type 2 diabetes mellitus (DM). We evaluated the relationship between urine albumin-to-creatinine ratio (UACR) and regional brain volumes to determine whether subclinical albuminuria may indicate early structural brain changes in type 2 DM. MATERIALS/ METHODS: We studied UACR and brain volumes in 85 type 2 DM patients (64.8±8.3years) and 40 age-matched controls using 3D magnetization prepared rapid acquisition with gradient echo (MP-RAGE) MRI (magnetic resonance imaging) at 3 Tesla. The relationship between UACR and brain volumes was analyzed using the least square models. RESULTS: In DM patients, UACR ≥5mg/g, UACR ≥10mg/g and clinically significant MA (UACR ≥17mg/g [males] and 25mg/g [females]) were associated with lower gray matter (GM) volume in the frontal lobe (r(2)adj=0.2-0.4, P=0.01-0.05) and UACR ≥5mg/g was also related to global GM atrophy (r(2)adj=0.1, P=0.04), independent of DM duration, glucose levels, HbA1c and hypertension. For UACR ≥5mg/g, a lower global GM volume was related to worse executive function (P=0.04) in the DM group. No associations were found for UACR (<5mg/g) and controls. CONCLUSIONS: Subclinical albuminuria (UACR ≥5mg/g) is associated with lower GM volume that has clinical impact on cognitive function in older diabetic patients, and these relationships are independent of DM control and hypertension. Therefore, UACR levels may serve as an additional marker of DM-related brain structural changes.
OBJECTIVE: Microalbuminuria (MA), a marker of renal microvascular disease, is associated with brain atrophy and neurovascular changes in older adults with type 2 diabetes mellitus (DM). We evaluated the relationship between urine albumin-to-creatinine ratio (UACR) and regional brain volumes to determine whether subclinical albuminuria may indicate early structural brain changes in type 2 DM. MATERIALS/ METHODS: We studied UACR and brain volumes in 85 type 2 DMpatients (64.8±8.3years) and 40 age-matched controls using 3D magnetization prepared rapid acquisition with gradient echo (MP-RAGE) MRI (magnetic resonance imaging) at 3 Tesla. The relationship between UACR and brain volumes was analyzed using the least square models. RESULTS: In DMpatients, UACR ≥5mg/g, UACR ≥10mg/g and clinically significant MA (UACR ≥17mg/g [males] and 25mg/g [females]) were associated with lower gray matter (GM) volume in the frontal lobe (r(2)adj=0.2-0.4, P=0.01-0.05) and UACR ≥5mg/g was also related to global GM atrophy (r(2)adj=0.1, P=0.04), independent of DM duration, glucose levels, HbA1c and hypertension. For UACR ≥5mg/g, a lower global GM volume was related to worse executive function (P=0.04) in the DM group. No associations were found for UACR (<5mg/g) and controls. CONCLUSIONS:Subclinical albuminuria (UACR ≥5mg/g) is associated with lower GM volume that has clinical impact on cognitive function in older diabeticpatients, and these relationships are independent of DM control and hypertension. Therefore, UACR levels may serve as an additional marker of DM-related brain structural changes.
Authors: Elsbeth C Witte; Hiddo J Lambers Heerspink; Dick de Zeeuw; Stephan J L Bakker; Paul E de Jong; Ronald Gansevoort Journal: J Am Soc Nephrol Date: 2008-12-17 Impact factor: 10.121
Authors: H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf Journal: JAMA Date: 2001-07-25 Impact factor: 56.272
Authors: Joshua I Barzilay; Peggy Gao; Martin O'Donnell; Johannes F E Mann; Craig Anderson; Robert Fagard; Jeffrey Probstfield; Gilles R Dagenais; Koon Teo; Salim Yusuf Journal: Arch Intern Med Date: 2011-01-24
Authors: Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels Journal: Diabetes Care Date: 2010-03-18 Impact factor: 19.112
Authors: E J Barbeau; J P Ranjeva; M Didic; S Confort-Gouny; O Felician; E Soulier; P J Cozzone; M Ceccaldi; M Poncet Journal: Neuropsychologia Date: 2007-12-04 Impact factor: 3.139
Authors: Joshua I Barzilay; Timothy M Morgan; Anne M Murray; R Nick Bryan; Jeff D Williamson; Adrian Schnall; Lenore J Launer Journal: J Gerontol A Biol Sci Med Sci Date: 2015-11-19 Impact factor: 6.053
Authors: Miae Jang; Sohee Oh; Hye-Mi Noh; Sunyoung Chun; Hye Young Oh; Kyung Hee Park; Yu Jin Paek; Hong Ji Song Journal: Korean J Fam Med Date: 2015-11-20